SPROUT PHARMACEUTICALS, INC.

Profile

Company Names

SPROUT PHARMACEUTICALS, INC.

Addresses

4208 SIX FORKS ROAD, SUITE 1010, RALEIGH, NC 27609

Phone Numbers

919-882-0850

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$89,303,861.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2015-05-22 
$50,000,008.00 
$50,000,008.00 
$0.00 
Equity 
4
2014-06-30 
$4,303,856.00 
$15,000,000.00 
$10,696,144.00 
Equity 
3
2013-06-11 
$9,999,997.00 
$10,000,000.00 
$3.00 
Equity 
2
2012-06-15 
$20,000,000.00 
$20,000,000.00 
$0.00 
Equity 
1
2012-03-08 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
W. 
DAHL 
DIRECTOR
SPROUT PHARMACEUTICALS, INC.
W. 
ROBERT 
DAHL 
DIRECTOR
ARROWHAWK DURABLE ALPHA, LP   |  ARROWHAWK DURABLE ALPHA, LTD.   |  SPROUT PHARMACEUTICALS, INC.   |  ROSEMORE CAPITAL, LLC   |  REMEDY PARTNERS, INC.   |  REMEDY PARTNERS, INC.   |  PAI HOLDING CO LLC   |  SPROUT2 INC.   |  CITY LIFT QOF INVESTORS, LLC
RICHARD 
 
DESCHUTTER 
DIRECTOR
SLATE PHARMACEUTICALS, INC.   |  SPROUT PHARMACEUTICALS, INC.
DOUGLAS 
 
ECKERT 
EXECUTIVE OFFICER, DIRECTOR
SLATE PHARMACEUTICALS, INC.   |  SPROUT PHARMACEUTICALS, INC.
MICHAEL 
 
FORD 
DIRECTOR
SLATE PHARMACEUTICALS, INC.   |  MEDPOINT HEALTH PARTNERS, LLC   |  SPROUT PHARMACEUTICALS, INC.   |  CAPITAL COMMUNITY BANCORPORATION, INC.   |  SKYDEO INC
RICH 
 
FRANCO 
EXECUTIVE OFFICER
SPROUT PHARMACEUTICALS, INC.
BRAXTON 
 
GOODRICH 
DIRECTOR
SPROUT PHARMACEUTICALS, INC.   |  UNDERCOVER COLORS, INC.   |  CHC PARTNERS HOLDINGS, INC.   |  RESBIOTIC, INC.   |  RESBIOTIC NUTRITION, INC.
TRYGVE 
 
MIKKELSEN 
DIRECTOR
SLATE PHARMACEUTICALS, INC.   |  AMKAI LLC   |  SPROUT PHARMACEUTICALS, INC.   |  BEST RESPONSE STRATEGIES LLC   |  NPHASE, INC.
MATTHEW 
 
PETZOLD 
EXECUTIVE OFFICER
SPROUT PHARMACEUTICALS, INC.   |  SPROUT2 INC.
FRED 
 
PRUDEN 
EXECUTIVE OFFICER
SPROUT PHARMACEUTICALS, INC.
JAMES 
 
PRUDEN 
EXECUTIVE OFFICER
SPROUT PHARMACEUTICALS, INC.
JAMES 
 
SYMONS 
EXECUTIVE OFFICER
SPROUT PHARMACEUTICALS, INC.
ANNE 
 
TOMALIN 
EXECUTIVE OFFICER
SPROUT PHARMACEUTICALS, INC.
JOSEPHINE 
 
TORRENTE 
EXECUTIVE OFFICER
SPROUT PHARMACEUTICALS, INC.   |  CONTINUITY BIOSCIENCES, LLC
CYNTHIA 
 
WHITEHEAD 
EXECUTIVE OFFICER, DIRECTOR
SPROUT PHARMACEUTICALS, INC.   |  SPROUT2 INC.
ROBERT 
S 
WHITEHEAD 
EXECUTIVE OFFICER, DIRECTOR
SPROUT PHARMACEUTICALS, INC.
ROBERT 
S. 
WHITEHEAD 
EXECUTIVE OFFICER, DIRECTOR
SPROUT PHARMACEUTICALS, INC.
ANTHONY 
 
WILD 
DIRECTOR
INNOCOLL HOLDINGS, INC.   |  SLATE PHARMACEUTICALS, INC.   |  SPROUT PHARMACEUTICALS, INC.   |  SERMONIX PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-06-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-22 
2014-07-11
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-06-30 
2013-07-26
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-11 
2013-06-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-11 
2012-07-11
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-15 
2012-06-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-15 
2012-03-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
N/A
NONE
NONE
NONE
N/A
NONE